BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.
|
Event: |
Stifel 2016 Healthcare Conference |
|
Date: |
Tuesday, November 15, 2016 |
|
Time: |
10:15 a.m. Eastern Standard Time |
|
Event: |
Jefferies 2016 Global Healthcare Conference |
|
Date: |
Thursday, November 17, 2016 |
|
Time: |
5:20 p.m. Greenwich Mean Time |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2016-healthcare-and-jefferies-2016-global-healthcare-conferences-300359249.html
SOURCE Array BioPharma Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
